Climb Bio, Inc. (CLYM) insider trading.
In Q3 2026, insiders at Climb Bio, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $1.4M.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -100,000
- Insiders
- 2
- Last filed
- 2026-09-30
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund II, L.P. / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M. / Kolchinsky Peter / RA Capital Nexus Fund III, L.P. | Director, TenPercentOwner | 4 | 0 | 0 |
| Thomas Stephen Basil | Director | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund II, L.P. / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M. / Kolchinsky Peter / RA Capital Nexus Fund III, L.P. | M (A) | 10,000 | $7.89 | 30,000 | Form 4 |
| 2026-09-28 | RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund II, L.P. / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M. / Kolchinsky Peter / RA Capital Nexus Fund III, L.P. | M (A) | 40,000 | $1.29 | 70,000 | Form 4 |
| 2026-09-28 | RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund II, L.P. / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M. / Kolchinsky Peter / RA Capital Nexus Fund III, L.P. | M (A) | 10,000 | $3.46 | 10,000 | Form 4 |
| 2026-09-28 | RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund II, L.P. / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M. / Kolchinsky Peter / RA Capital Nexus Fund III, L.P. | M (A) | 10,000 | $3 | 20,000 | Form 4 |
| 2026-09-15 | Thomas Stephen Basil | S (D) | 100,000 | $13.67 | 467,969 | Form 4 |
Transaction codes in this quarter
Get CLYM insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1768446&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CLYM company page · Climb Bio, Inc. on SEC.gov
Questions
Are insiders buying or selling Climb Bio, Inc. (CLYM)?
In Q3 2026, insiders at Climb Bio, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $1.4M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Climb Bio, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/clym.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.